Search results
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 17 hours agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoCAR-T drugs are developed using a patient's own immune cells. Promisingly, Pfizer said in February...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 1 day agoModerna emphasized the FDA has not said it found any issues related to vaccine effectiveness, safety...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 5 days agoWilliam Blair analyst...backlogs, today's news does not alter our expectation that (Moderna's RSV ...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 1 day agoThe deal is a negative for Covid vaccine rivals Pfizer and Moderna, Leerink Partners analyst David...
AstraZeneca withdraws Covid-19 vaccine, citing low demand - Boston News, Weather, Sports | WHDH...
7 News Boston· 7 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 7 days agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe speed and flexibility required in clinical trials for COVID-19 set a new precedent for what can...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoThe Food and Drug Administration (FDA) notified Moderna Inc MRNA on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints ...
A Novel Broad-Spectrum Antiviral with Activity Against RSV
Digital Journal· 2 days agoSHELTON, CT / ACCESSWIRE / May 14, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV ...